European Association of Dermato-Oncology 14th European Post-Chicago Melanoma Skin Cancer Meeting 2024

European Association of Dermato-Oncology 14th European Post-Chicago Melanoma Skin Cancer Meeting 2024

Include: 26 videos + 1 pdf, size: 21.1 GB

 Target Audience: dermatologists, oncologists, pathologists

 Information:

The 14th European Post-Chicago Melanoma Skin Cancer Meeting 2024 is designed for medical professionals specializing in melanoma and skin cancer treatment. The target audience includes:

• Dermatologists and oncologists focused on melanoma and skin cancer.
• Clinical researchers involved in melanoma diagnostics and therapy.
• Pathologists specializing in skin cancer histopathology.
• Medical professionals interested in immuno-oncology and targeted therapies.
• Industry experts working on drug development and clinical trials.

This interdisciplinary conference provides a comprehensive overview of the latest advancements in melanoma diagnostics, treatment strategies, and emerging therapies. It fosters direct communication between clinicians, researchers, and industry representatives

Topics:

• 16_EPCM-2024_FINAL-Program_web.pdf
  CLOSING REMARKS.mp4
  KEYNOTE LECTURE I.mp4
  KEYNOTE LECTURE II.mp4
  KEYNOTE LECTURE III.mp4
  KEYNOTE LECTURE IV.mp4
  OPENING OF THE CONFERENCE.mp4
  PARALLEL SYMPOSIUM I Adverse event management of targeted and immunotherapies.mp4
  PARALLEL SYMPOSIUM II Real world evidence studies from registries.mp4
  PARALLEL SYMPOSIUM III Cutaneous T-cell lymphoma (CTCL).mp4
  PARALLEL SYMPOSIUM IV Interactive Discussion of complex melanoma cases.mp4
  PARALLEL SYMPOSIUM V Interactive Discussion of complex non-melanoma cases.mp4
  PARALLEL SYMPOSIUM VI Innovative therapies for orphan diseases.mp4
  SATELLITE SYMPOSIUM I NOVARTIS Gold Sponsor Yesterday, Today & Tomorrow Long-Term Benefits with Targeted Therapy in Adjuvant Melanoma.mp4
  SATELLITE SYMPOSIUM II BMS Gold Sponsor IO-Combinations in Melanoma- How to Proceed – Less or More.mp4
  SATELLITE SYMPOSIUM III MSD Platinum Sponsor Advancements in Early Melanoma Integrating Recent Updates into Clinical Practice.mp4
  SATELLITE SYMPOSIUM V REGENERON Platinum Sponsor Evolving Perspectives on Treatment Roadmap for Advanced Non-melanoma Skin Cancer.mp4
  SATELLITE SYMPOSIUM VI PHILOGEN Sponsor Novel treatments for locally advanced skin cancers.mp4
  SATELLITE SYMPOSIUM VII MERCK Bronze Sponsor Leveraging Real-World Evidence in Advanced Merkel Cell Carcinoma- Insights from Clinical Practice.mp4
  SYMPOSIUM I My personal highlights at ASCO 2024.mp4
  SYMPOSIUM II Which vaccines work and which not.mp4
  SYMPOSIUM III The role of gut microbiome for immunooncology.mp4
  SYMPOSIUM IV Bispecific T-cell engagers (BTE) in cutaneous and uveal melanomas (unrestricted Educational Grant Immunocore).mp4
  SYMPOSIUM V Controversy- Is neoadjuvant or perioperative ICI already standard of care.mp4
  SYMPOSIUM VI Adjuvant treatment of melanoma.mp4
  SYMPOSIUM VII Intralesional therapies for melanoma and NMSC.mp4
  SYMPOSIUM VIII What’s new in NMSC Publication highlights from the last 12 months.mp4